Literature DB >> 19769189

Proteomic analyses of recombinant human follicle-stimulating hormone and urinary-derived gonadotropin preparations.

Yoshimitsu Kuwabara1, Katsuya Mine, Akira Katayama, Tomoko Inagawa, Shigeo Akira, Toshiyuki Takeshita.   

Abstract

OBJECTIVE: To understand the properties of each available gonadotropin preparation, especially in terms of the differences between urinary-derived and recombinant preparations. STUDY
DESIGN: Human menopausal gonadotropin (hMG), highly purified urinary-derived follicle-stimulating hormone (uFSH-HP) and recombinant FSH (rFSH) were subjected to 2-dimensional gel electrophoresis (2-DE), and protein spots were visualized by silver-staining procedures. Major spots were analyzed by mass spectrometry. Fluorescent-labeled preparations were also subjected to 2-DE to evaluate the quantities of FSH isohormones contained in each preparation.
RESULTS: 2-DE and mass spectrometry analyses of hMG identified many extracellular proteins as major impurities and several plasma membrane proteins including prion proteins. Both uFSH-HP and rFSH demonstrated slight impurities and showed several alpha and beta subunit isohormones. rFSH contained higher amounts of the basic isohormones of the alpha subunit than uFSH-HP, whereas the predominance of the basic isohormones was less significant in the beta subunit.
CONCLUSION: Proteomic analyses demonstrated the detailed protein profiles of each preparation. Differences in the quantities of alpha subunit isohormones may contribute to the variations in FSH activity observed between recombinant and urinary-derived FSH preparations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19769189

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.

Authors:  Robert Cunningham; Di Ma; Lingjun Li
Journal:  Front Biol (Beijing)       Date:  2012-08-01

2.  Detection of prion protein in urine-derived injectable fertility products by a targeted proteomic approach.

Authors:  Alain Van Dorsselaer; Christine Carapito; François Delalande; Christine Schaeffer-Reiss; Daniele Thierse; Hélène Diemer; Douglas S McNair; Daniel Krewski; Neil R Cashman
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

Review 3.  Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.

Authors:  Rogério de Barros F Leão; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 4.  A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.

Authors:  Diego Ezcurra; Peter Humaidan
Journal:  Reprod Biol Endocrinol       Date:  2014-10-03       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.